Nervous system involvement in Behçet's syndrome

Uygunoglu U., Siva A.

Current opinion in rheumatology, cilt.31, ss.32-39, 2019 (Diğer Kurumların Hakemli Dergileri) identifier identifier identifier

  • Cilt numarası: 31 Konu: 1
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1097/bor.0000000000000562
  • Dergi Adı: Current opinion in rheumatology
  • Sayfa Sayıları: ss.32-39


Behcet's syndrome (BS), a distinct disease with orogenital ulceration and uveitis known as the triple-symptom complex, is an idiopathic chronic relapsing multisystem vascular-inflammatory disease of unknown origin. The neurological involvement of BS is termed as neuro-Behcet's syndrome (NBS). Direct neurological involvement of BS may be classified into two forms: (1) parenchymal (p-NBS) and (2) vascular involvement. p-NBS with the rate of 75% among neurological involvements of BS usually presents with an acute-subacute brain stem syndrome. Headache, cranial neuropathy, dysarthria, ataxia, and hemiparesis are the most prominent symptoms. The most common areas affected in p-NBS are the mesodiencephalic junction (MDJ), pons, and medulla oblongata. MDJ lesions tend to extend upward to involve the diencephalic structures and downward to involve the pontobulbar region which is the most common radiological finding observed in p-NBS. The only drug that has been shown to be effective based on the Class IV evidence is infliximab for the treatment of p-NBS.